DOI:
10.1055/s-00044025
Annals of the National Academy of Medical Sciences (India)
LinksClose Window
References
Masmiquel L, Leiter LA, Vidal J. et al; LEADER investigators.
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
Cardiovasc Diabetol 2016;
15: 29
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.